Differential Expression and Cell Cycle Regulation of the Cyclin-dependent Kinase 4 Inhibitor p16Ink

Cancer Research

Volumn 54, Issue 22, 1994, Pages 5816-5820

  Shay, Jerry W ^b   Pagano1, Michele ^a  

^a GPC Biotech Inc   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PHOSPHOTRANSFERASE; PROTEIN P16; PROTEIN P21;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL CYCLE; CELL LINE, TRANSFORMED; CONNECTIVE TISSUE; EPITHELIUM; G1 PHASE; HUMAN; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; S PHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0028126668     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Serrano, M. Hannon, G.J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/Cdk4. Nature (Lond.), 366: 704-707, 1993.
2. Kamb, A. Gruis, N. Weaver-Feldhaus, J. Liu, Q. Harshman, K. Tavtigian, S. Stockert, E. Day, R. Ill, Johnson, B. and Skolnock, M. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
3. Nobori, T. Miura, K. Wu, D. Lois, A. Takabayashi, K. and Carson, D. Deletions of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
4. Mori, T. Miura, K. Aoki, T. Nishihira, T. Mori, S. and Nakamura, Y. Frequent somatic mutation of the Mtsl/Cdk4 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal cell carcinoma. Cancer Res. 54: 3396-3397, 1994.
5. Okamoto, A. Demetrick, D.J. Spillare, E. Hagiwara, K. Hussain, P. Bennett, W.P. Forrester, K. Gerwin, B. Serrano, M. Beach, D. and Harris, C.C. Mutations and altered expression of p. 6Ink4 in human cancer. Proc. Natl. Acad. Sci. USA, in press, 1994.
6. Spruck, C. Gonzalez-Zulueta, M. Shibata, A. Simoneau, A. Lin, M. Gonzales, F. Tsai, Y. and Jones, P. p. 6 gene in uncultured tumours. Nature (Lond.), 370: 183-184, 1994.
7. Sherr, C.J. Mammalian G1 cyclins. Cell, 73: 1059-1065, 1993.
8. Harper, J.W. Adami, G.R. Wei, N. Keyomarsi, K. and Elledge, S.J. The p. 1 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
9. Xiong, Y. Hannon, G. Zhang, H. Casso, D. Kobayashi, R. and Beach, D. p. 1 is a universal inhibitor of the cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
10. Dulic, V. Kaufmann, W. Wilson, S. Tlsty, T. Lees, E. Harper, W. Elledge, S. and Reed, S. p. 3-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76: 1013-1023, 1994.
11. Zhang, H. Hannon, G. and Beach, D. p. 1-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758, 1994.
12. Pagano, M. Draetta, G. and Jansen-Durr, P. Association of cdk2 kinase with the transcription factor E2F during S phase. Science (Washington DC), 255: 1144-1147, 1992.
13. Pagano, M. Theodoras, A.M. Tam, S.W. and Draetta, G. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes & Dev. 8: 1627-1639, 1994.
14. Lukas, J. Pagano, M. Staskova, Z. Draetta, G. and Bartek, J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene, 9: 707-718, 1994.
15. Wright, W. Pereira-Smith, O. and Shay, J. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol. 9; 3088-3092, 1989.
16. Shay, J. Wright, W. Brasiskyte, D. and Van Der Haegen, B. E6 of human papillomavirus type 16 can overcome the Ml stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene, 8: 1407-1413, 1993.
17. Tam, S.W. Theodoras, A.M. Shay, J.W. Draetta, G.F. and Pagano, M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene, 9: 2663-2674, 1994.
18. Pagano, M. Pepperkok, R. Lukas, J. Baldin, V. Ansorge, W. Bartek, J. and Draetta, G. Regulation of the human cell cycle by the cdk2 protein kinase. J. Cell Biol. 121: 101-111, 1993.
19. Jenkins, C.W. and Xiong, Y. Immunoblotting and immunoprecipitation in cell cycle studies. In: M. Pagano (ed.), Cell Cycle: Materials and Methods, in press, 1995.
20. Meyerson, M. and Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077-2086, 1994.
21. Xiong, Y. Zhang, H. and Beach, D. D Type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 504-514, 1992.
22. Gu, Y. Turck, C. and Morgan, D. Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993.
23. El-Deiry, W.S. Tokino, T. Velculescu, V.E. Levy, D.B. Parsons, R. Trent, J.M. Lin, D. Mercer, W.E. Kinzler, K.W. and Vogelstein, B. WAFl, a potential mediator of p. 3 tumor suppression. Cell, 75: 817-825, 1993.
24. Noda, A. Ning, Y. Venable, S. Pereira-Smith, O. and Smith, R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. J. Exp. Cell. Res. 211: 90-98, 1994.
25. Moran, E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Gen. Dev. 3: 63-70, 1993.
26. Lukas, J. Müller, H. Bartkova, J. Spitkovsky, D. Kjerulff, A. Jansen-Durr, P. Strauss, M. and Bartek, J. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G, J. Cell Biol. 125: 625-638, 1994.
27. Müller, H. Lukas, J. Schneider, A. Warthoe, P. Bartek, J. Eilers, M. and Strauss, M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 91: 2945-2949, 1994.
28. Farthing, A. and Vousden, K.H. Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol. 2: 170-175, 1994.
29. Sherr, C.J. Kato, J. Quelle, D. Matsuoka, M. and Roussel, M. D-type cyclins and their cyclin-dependent kinases: G, phase integrators of the mitogenic response. Cold Spring Harbor Symp. Quant. Biol. in press, 1994.
30. Vousden, K.H. Vojtesek, B. Fisher, C. and Lane, D. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p. 3. Oncogene, 8: 1697-1702, 1993.
31. Hickman, E. Picksley, S. and Vousden, K.H. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p. 3 activation. Oncogene, 9: 2177-2181, 1994.
32. Baldin, V. Lukas, J. Marcote, M.J. Pagano, M. and Draetta, G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes & Dev. 7: 812-821, 1993.
33. Quelle, D. Ashmun, R. Shurtleff, S. Kato, J. Bar-Sagi, D. Roussel, M. and Sherr, C. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes & Dev. 7: 1559-1571, 1993.
34. Sherr, C.J. The ins and outs of Rb: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4: 15-18, 1994.